GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a substantial shift in how we treat type 2 diabetes . These prescription therapies help stimulating the body’s inherent GLP-1 substance , https://socialmediatotal.com/story6770600/glp-1-a-revolutionary-advance-in-glucose-treatment